Estee Gold Feet Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Estee Gold Feet Tbk. trades at Rp1,735 (market cap 4.49T, 735.5K 24h volume), while Prodia Diagnostic Line Tbk trades at Rp264 (market cap 470.58B, 18.86M 24h volume). The key difference: Estee Gold Feet Tbk. is far larger — about 9.5× Prodia Diagnostic Line Tbk's market cap, and Prodia Diagnostic Line Tbk is more actively traded (18.86M versus 735.5K). Which is the better fit depends on your goals.
| EURO | PRDL | |
|---|---|---|
Market Cap | 4.49T | 470.58B |
Volume | 735.5K | 18.86M |
Lot | 7.36K | 188.57K |
Turnover | 1.32B | 4.97B |
Average Price | 1,791.32 | 263.63 |
Value | 1.32B | 4.97B |
Indicative Equilibrium Price | 1,735 | 264 |
Indicative Equilibrium Volume | 62 | 3.64K |
Trailing returns across standard periods
Latest headlines on both assets
PT Estee Gold Feet Tbk (Company) was established by Notarial Deed No. 32 dated January 21, 1980 from Abdoel Sjoekoer, S.H., Notary in Jakarta. The Company started its commercial operations in 1986. The Company is controlled by its immediate parent company, PT Timmsvale, a company domiciled in Indonesia. The ultimate beneficial owners of the Company are Johansen Ngian.
Read more on EURO →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →